Skip to content

Home > Giving Initiatives > Type 1 Diabetes

Pediatric Type 1 Diabetes

Innovative Treatments and New Paths to a Cure

Every child with type 1 diabetes yearns for a life without limits, but managing their disease is complex, and even small missteps can have severe consequences. We know this problem can be solved through research—with philanthropy, we can accelerate the pace to find solutions.

The Right People in the Right Place

The pediatric diabetes program at Stanford is ranked as one of the best in the country, where physician scientists and clinicians are focused on making type 1 diabetes a thing of the past. We’re working on detecting early type 1 diabetes, delaying its onset, preventing, and eventually curing this chronic condition. Our mission includes leveraging technology to enhance health outcomes, and leveling the playing field to help every patient, regardless of economic status.

Meet the Leader of Pediatric Type 1 Diabetes Research at Stanford

Pediatric endocrinologist David Maahs, MD, PhD, specializes in large epidemiologic studies to identify clinical problems and generate hypotheses for randomized clinical trials (RCT). The RCTs test interventions to improve care for children with type 1 diabetes.

Recently, Dr. Maahs oversaw a revolutionary study on the early introduction of diabetes technology. The results were dramatic: A majority of participants—children with new-onset type 1 diabetes—had significantly reduced their average blood sugar level 12 months after diagnosis.

Thanks to Stanford’s cutting-edge investigative infrastructure, important work like this is taking place every day, Dr. Maahs says. That’s hopeful news for kids and families dealing with type 1 diabetes.

"We envision a future where no child misses out on making meaningful memories or is held back because of their diabetes."

David Maahs, MD, PhD, Lucile Salter Packard Professor of Pediatrics and Division Chief of Pediatric Endocrinology

Opportunities for Impact

Philanthropy can make a difference by enabling us to reduce the burden on kids with type 1 diabetes and their families. With your help we can:

Advance science and clinical care by studying genetics.

Anna Gloyn, DPhil, is investigating human genetics to identify safe and effective drug targets, improve islet-cell replacement therapy, and develop more precise and individualized treatments. Philanthropy will allow Dr. Gloyn to build a team of postdoctoral researchers to drive these lines of inquiry.

Reduce disparities and broaden access to care.

Priya Prahalad, MD, leads a pilot program to reduce disparities in care and outcomes. Philanthropy can further broaden our digital health capacity to provide care for kids in rural or underserved communities who can’t easily see endocrinologists or other specialists.

Make exercise easier and safer with technology.

Dessi Zaharieva, PhD, is one of the few PhDs in exercise science to focus on assisting children with diabetes. Kids can learn the benefits of physical activity through diabetes technology she is developing.
Philanthropy can make it easier for them to increase their overall activity.

Learn How You Can Help

With philanthropy and a dedicated, multi-disciplinary team of experts, we can give every child a fighting chance against type 1 diabetes.

Helping Children Thrive

When Dessi Zaharieva was 7 years old, she had a big year. She began to take lessons in taekwondo and kick-started a decades-long journey—one that...

Billee (left) and Michael (right) with their granddaughter, Taylor, now a thriving young adult. Michael and Isabel “Billee” Schneider have been part of the Stanford...

Yesterday we sat down with our friends in the Diabetes and Endocrinology program to hear research insights from our renowned scientists, David Maahs, MD, PhD,...